SparkBio
SparkBio is a privately-held Italian medical technology firm (founded 1995, Bologna) that is the exclusive Italian distributor of the Finapres NOVA non-invasive blood pressure monitor and the developer of OneViewX, a proprietary medical-grade video and signal acquisition platform used in surgical rooms for remote clinical education.
- Company typePrivate
- Founded1995
- HeadquartersSan Lazzaro Di Savena, Italy
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What SparkBio does
SparkBio S.r.l. is a privately-held Italian medical technology company founded in 1995 and headquartered in San Lazzaro di Savena, near Bologna. The firm operates with a small team (1-10 employees) and combines proprietary medical device engineering with exclusive distribution and authorized service for third-party products. Its current commercial offering is anchored by two pillars: (i) the Finapres NOVA, a CE-marked non-invasive continuous blood pressure monitor with a 13-inch touch screen, double finger cuff system for 24/7 patient-friendly measurement, and a modular architecture expandable with additional hardware modules and software applications, distributed by SparkBio as the exclusive Italian partner of Finapres Medical Systems B.V.; and (ii) OneViewX, a proprietary medical-grade software platform for recording, streaming, editing, and sharing video and analog signals captured in surgical and interventional rooms, marketed to surgical and cardiology departments seeking to establish Permanent Live Case Centers for remote clinical education.
The company's revenue model blends hardware sales (Finapres NOVA monitors, finger cuffs, and accessories), recurring aftermarket services (exclusive authorized maintenance, calibration, spare parts, and repair for both current and legacy Finapres devices installed in Italy — Finometer PRO, Finometer MIDI, and Portapres), and proprietary software (OneViewX). Go-to-market is enterprise field sales targeting hospitals, cardiology and neurology departments, neurophysiology laboratories, and clinical research institutions, augmented by direct inbound via website and email and a separate oneviewx.com digital presence for international outreach. Historically, SparkBio developed CE-marked neurovascular polygraphic systems for syncope/neurological disease study and a patented automatic carbon dioxide angiography system (CE-marked end-2011); both remain part of the legacy portfolio. Pricing is quote-based and not publicly disclosed, with SparkBio offering customized configurations of the Finapres NOVA platform.
Strategically, SparkBio has shifted emphasis since 2014 toward its OneViewX software platform while maintaining the lucrative Finapres exclusive distribution and authorized-service franchise in Italy. The firm holds one granted patent (automatic CO2 angiography system), multiple CE marks, and 25 years of clinical relationships, but operates at sub-10 headcount with no disclosed institutional backing, funding events, or named customer logos in the available record. Source IDs primarily supporting these facts include (firmographic profile and product positioning) (technology, history, and proprietary systems) (Finapres NOVA details and distribution agreement) (channel partnership and distribution scope), (OneViewX product positioning).
SparkBio firmographics
Firmographics- Name
- SparkBio
- Legal name
- SparkBio
- Website
- https://sparkbio.it
- Company type
- Private
- Founded year
- 1995
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- SparkBio is a privately-held Italian medical technology firm (founded 1995, Bologna) that is the exclusive Italian distributor of the Finapres NOVA non-invasive blood pressure monitor and the developer of OneViewX, a proprietary medical-grade video and signal acquisition platform used in surgical rooms for remote clinical education.
- Ownership category
- akta.pro rank
SparkBio industry classification
Industry- Product category
- Medical Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT) (HLAHAFAI)
- akta.pro secondary industries
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Cardiology Telemedicine Platforms (HLALAGAB)
Keywords
Where SparkBio is headquartered
LocationHeadquarters
- HQ city
- San Lazzaro Di Savena
- HQ country
- Italy
- HQ region
- Europe
Offices1 record
Markets served
SparkBio business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales
Revenue model
- Medical Device Distribution: Exclusive distribution of Finapres Medical Systems products in Italy including the NOVA blood pressure monitor, finger cuffs, and related accessories. Revenue generated from product sales with 25 years of industry experience supporting configuration and sales.
- Proprietary Software Platforms: Sales of proprietary software including OneViewX for video/signal acquisition in surgical environments and cardiac rehabilitation management platforms. Marketed in selected markets worldwide.
- Maintenance and Calibration Services: Exclusive authorized partner managing maintenance, repairs, calibration, and spare parts for Finapres devices in Italy. Covers legacy devices including Finometer PRO, Finometer MIDI, and Portapres.
Go-to-market motion2 records
Distribution channels2 records
Marketing channels2 records
SparkBio product offering
Product offeringCore offering
SparkBio develops proprietary medical technology for cardiology and neurology applications, including the OneViewX surgical video and signal acquisition platform. The company serves as the Italian exclusive distributor for Finapres Medical Systems B.V., handling sales, installation, and authorized maintenance of the Finapres NOVA non-invasive continuous blood pressure monitor. SparkBio also provides maintenance, calibration, and spare parts services for the installed Finapres device base in Italy.
Product overview
SparkBio operates as a medical technology company offering a portfolio of proprietary medical devices and software. The current core products are the Finapres NOVA (a modular non-invasive continuous blood pressure monitoring system distributed exclusively in Italy) and the OneViewX platform (a medical-grade video/analog signal recording, streaming, editing, and sharing system for surgical and interventional rooms). Historically, the company also developed CE-marked neurovascular polygraphic systems, a carbon dioxide angiography system, and cardiac rehabilitation software, and currently supports legacy installed bases through authorized repair and calibration services.
Differentiator
Problem solved
Functional benefit
Brands
- OneViewX: A modern software technology for video and analog signals acquisition at surgery and interventional rooms, designed to enable Permanent Live Case Centers for Remote Education and Support.
Products and services
- Finapres NOVA A cutting-edge non-invasive continuous blood pressure monitor featuring a 13-inch touch screen, a double finger cuff system enabling 24/7 patient-friendly measurement, and a modular architecture allowing expansion with hardware modules and software applications. SparkBio is the Italian exclusive distributor for hospitals, cardiology departments, and clinical research institutions.
- OneViewX A medical-grade software platform for recording, streaming, editing, and sharing surgical and interventional procedures, enabling Permanent Live Case Centers for remote clinical education and support worldwide. Designed for surgical departments, interventional radiology/cardiology centers, and clinical educators.
- Finapres Repairs & Calibration Services Authorized maintenance, calibration, and spare parts (HCU, Finger Cuff, other accessories) services for Finapres devices installed in Italy, including discontinued Finometer PRO, Finometer MIDI, and Portapres models.
- Neurovascular Polygraphic Systems Proprietary CE-marked neurovascular polygraphic systems for the study of syncope and neurological diseases, originally developed in 1995 and marketed exclusively in selected markets worldwide.
- Carbon Dioxide Angiography System A patented and exclusive automatic system for carbon dioxide angiography, CE-marked in 2011, used for imaging in endovascular procedures as a radiation-free alternative.
- Cardiac Rehabilitation Management Software A software platform for cardiac rehabilitation management in hospital gyms and at home, developed starting in 2008.
- Syncope Unit and Neurophysiology Laboratory Suite A complete suite of products and services for Syncope Units and Neurophysiology laboratories, rationalized in 2011 as part of the company's core business restructuring.
Quantifiable outcome
- Non-invasive continuous blood pressure measurement available 24/7 with patient-friendly finger cuff technology
- +1 more outcomes
Companies that use SparkBio
Customer profileSegments4 records
Ideal customer profiles4 records
SparkBio technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
SparkBio partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Finapres Medical Systems B.V.coreSparkBio is the Italian exclusive distributor for Finapres Medical Systems B.V. Since 2011, SparkBio has handled national distribution of Finapres products including the NOVA blood pressure monitor. The company also serves as the exclusive authorized partner to manage all maintenance on existing installed Finapres devices in Italy, including legacy products (Finometer PRO, Finometer MIDI, Portapres) and provides spare parts, calibration services, and repairs.
Scale indicators3 records
Recent moves5 records
Expansion highlights4 records
SparkBio competitors and assessment
Company assessmentEmerging players
- Caretaker Medical: Caretaker Medical builds a wireless, cuffless continuous non-invasive blood pressure monitor using finger-PPG technology, a direct technological analogue of the Finapres NOVA's continuous finger-cuff approach and serving the same hemodynamic monitoring use cases.
- Biobeat Technologies: Biobeat makes wearable, cuffless continuous blood pressure and vital sign monitors for hospital and remote patient monitoring, overlapping with the Finapres NOVA's continuous BP use case and the broader cardiometabolic RPM trend SparkBio touches through Finapres and its legacy cardiac rehab software.
Direct peers
- Proximie: Proximie is a remote surgical collaboration platform that allows surgeons to virtually scrub into procedures, share expertise, and educate peers worldwide, overlapping directly with OneViewX's Permanent Live Case Center model for interventional rooms.
- Uscom Limited: Uscom develops non-invasive cardiovascular monitoring devices (USCOM 1A, BP+) used for hemodynamics, sepsis, and hypertension management, providing a direct technological parallel to the Finapres NOVA in the cardiology and critical care monitoring space.
- Deltex Medical Group plc: Deltex Medical provides non-invasive and minimally invasive hemodynamic monitoring (oesophageal Doppler, TrueVue) to clinicians, overlapping with the Finapres NOVA and the neurovascular diagnostic workflow SparkBio supports in cardiology and neurology.
- CNSystems Medizintechnik AG: CNSystems develops non-invasive hemodynamic monitoring solutions including continuous blood pressure and cardiac output, overlapping directly with the Finapres NOVA product family. Both companies target the same clinical hemodynamic monitoring use case in hospitals and research institutions.
- Finapres Medical Systems B.V. Finapres is the manufacturer of the Finapres NOVA and the originator of the non-invasive continuous blood pressure technology that SparkBio distributes in Italy. While it is also SparkBio's supplier, it is the most direct comparability anchor because its products define the category SparkBio sells into.
Broad incumbents
- Edwards Lifesciences: Edwards is a global leader in hemodynamic and critical care monitoring, with invasive and minimally invasive platforms (e.g., FloTrac, ClearSight) that compete against Finapres-style non-invasive continuous BP in the same cath lab, OR, and ICU segments.
- LiDCO (Masimo): LiDCO, now part of Masimo, offers non-invasive and minimally invasive hemodynamic monitoring technologies, including continuous BP and cardiac output. It is a direct functional competitor to the Finapres NOVA in hemodynamic monitoring.
- Brainlab: Brainlab provides integrated surgical video capture, OR digitization, and remote collaboration tools used by hospitals and surgeons globally, broadly competing with the OneViewX platform while also serving neurosurgery and interventional workflows SparkBio addresses.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
SparkBio financial estimates
Financial estimateRevenue estimate
Valuation estimate
SparkBio leadership team
Management profileNumber of profiles
SparkBio funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SparkBio M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SparkBio
What does SparkBio do?
SparkBio develops proprietary medical technology for cardiology and neurology applications, including the OneViewX surgical video and signal acquisition platform. The company serves as the Italian exclusive distributor for Finapres Medical Systems B.V., handling sales, installation, and authorized maintenance of the Finapres NOVA non-invasive continuous blood pressure monitor. SparkBio also provides maintenance, calibration, and spare parts services for the installed Finapres device base in Italy.
Is SparkBio a public or private company?
SparkBio is a private company. It is classified as unknown and is currently operating.
When was SparkBio founded?
SparkBio was founded in 1995. It employs 1 to 10 people.
Where is SparkBio based?
SparkBio is headquartered in San Lazzaro Di Savena, Italy, in the Europe region.
How does SparkBio make money?
Three revenue lines are on record. Medical Device Distribution is the primary driver. The others are proprietary Software Platforms and maintenance and Calibration Services.
Who are SparkBio's main competitors?
Emerging players on record are Caretaker Medical and Biobeat Technologies. Direct peers are Proximie, Uscom Limited, Deltex Medical Group plc, CNSystems Medizintechnik AG and Finapres Medical Systems B.V.. Broad incumbents are Edwards Lifesciences, LiDCO (Masimo) and Brainlab.
Does SparkBio have an API?
No public API is recorded for SparkBio.
What industry is SparkBio in?
SparkBio's product category is Medical Devices. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity). Its NAICS code is 334510 and its SIC code is 3845.